Johnson Dermatology

Futó vizsgálatok

• Fut, nem toboroz

  A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

  NCT06143878· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

  NCT06095102· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

  NCT06095115· 3. fázis· Forrás

• Fut, nem toboroz

  A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

  NCT03661866· Forrás

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

  NCT06973291· 3. fázis· Forrás

• Lezárult

  Candin for the Treatment of Common Warts

  NCT05889845· 3. fázis· Forrás

• Lezárult

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

  NCT06588283· 3. fázis· Forrás

• Lezárult

  Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

  NCT05908240· Forrás

• Leállították

  A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

  NCT05491447· 2. fázis· Forrás

• Lezárult

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· 3. fázis· Forrás

• Lezárult

  Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

  NCT04036435· 3. fázis· Forrás

• Lezárult

  Light Treatment Effectiveness (LITE) Study

  NCT03726489· Forrás